AgingResearch.NewsJoin free

Iovance Biotherapeutics

Organisation

Trials

  • NCT07288073

    Collaborator, Phase 2, Recruiting, 14 people, 17 Dec 2025

  • NCT06190249

    Collaborator, Phase 1, Withdrawn, 0 people, 5 Jan 2024

  • NCT06151847

    Collaborator, Phase 2, Completed, 11 people, 30 Nov 2023

  • NCT03645928

    Phase 2, Terminated, 225 people, 24 Aug 2018

  • NCT03610490

    Collaborator, Phase 2, Terminated, 16 people, 1 Aug 2018

  • NCT03215810

    Collaborator, Phase 1, Completed, 20 people, 12 Jul 2017